Clinicians dilemma in the management of acute flare-up wheeze with asthma: An update

Abstract

Asthma is the earliest onset of non-communicable respiratory disease with a significant psycho-socio economic burden. Each country have their own guidelines to manage asthma for their need based on availability, accessibility, and affordability. The acute flare-up of asthma, where there is a progressive increase of symptoms of asthma, causing higher morbidity and mortality. The clinician often confronts with a dilemma in the management – in confirming the diagnosis of asthma, look for the risks for flare-up and mortality, followed by assessing the severity of flare-up for proper management. There is some dilemma in using the nebulized steroid in acute flare-up of asthma. The author highlights the current knowledge in clearing those issues for the practicing clinicians.